Considering the recent COVID-19 pandemic, it is worth noting that seropositivity to SARS-CoV-2, due to infection or immunization, did not impact Hsp90α concentration measurements, as both groups of seropositive patients had comparable serum Hsp90α levels when compared to seronegative donors. This evidence concerns the gene HSP90AA1 and infection.